Literature DB >> 11443114

Down-regulation of the alpha-Gal epitope expression in N-glycans of swine endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene. Modulation of the biosynthesis of terminal structures by a bisecting GlcNAc.

S Koyota1, Y Ikeda, S Miyagawa, H Ihara, M Koma, K Honke, R Shirakura, N Taniguchi.   

Abstract

The down-regulation of the alpha-Gal epitope (Galalpha1,3Galbeta-R) in swine tissues would be highly desirable, in terms of preventing hyperacute rejection in pig-to-human xenotransplantation. In an earlier study, we reported that the introduction of the beta1,4-N-acetylglucosaminyltransferase (GnT) III gene into swine endothelial cells resulted in a substantial reduction in the expression of the alpha-Gal epitope. In this study, we report on the mechanism for this down-regulation of the alpha-Gal epitope by means of structural and kinetic analyses. The structural analyses revealed that the amount of N-linked oligosaccharides bearing the alpha-Gal epitopes in the GnT-III-transfected cells was less than 10% that in parental cells, due to the alteration of the terminal structures as well as a decrease in branch formation. In addition, it appeared that the addition of a bisecting GlcNAc, which is catalyzed by GnT-III, leads to a more efficient sialylation rather than alpha-galactosylation. In vitro kinetic analyses showed that the bisecting GlcNAc has an inhibitory effect on alpha-galactosylation, but does not significantly affect the sialylation. These results suggest that the bisecting GlcNAc in the core is capable of modifying the biosynthesis of the terminal structures via its differential effects on the capping glycosyltransferase reactions. The findings may contribute to the development of a novel strategy to eliminate carbohydrate xenoantigens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443114     DOI: 10.1074/jbc.M102371200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice.

Authors:  Xiangchun Wang; Shinya Inoue; Jianguo Gu; Eiji Miyoshi; Katsuhisa Noda; Wenzhe Li; Yoko Mizuno-Horikawa; Miyako Nakano; Michio Asahi; Motoko Takahashi; Naofumi Uozumi; Shinji Ihara; Seung Ho Lee; Yoshitaka Ikeda; Yukihiro Yamaguchi; Yoshiya Aze; Yoshiaki Tomiyama; Junichi Fujii; Keiichiro Suzuki; Akihiro Kondo; Steven D Shapiro; Carlos Lopez-Otin; Tomoyuki Kuwaki; Masaru Okabe; Koichi Honke; Naoyuki Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-18       Impact factor: 11.205

2.  Bisecting GlcNAc Is a General Suppressor of Terminal Modification of N-glycan.

Authors:  Miyako Nakano; Sushil K Mishra; Yuko Tokoro; Keiko Sato; Kazuki Nakajima; Yoshiki Yamaguchi; Naoyuki Taniguchi; Yasuhiko Kizuka
Journal:  Mol Cell Proteomics       Date:  2019-08-02       Impact factor: 5.911

Review 3.  Neural functions of bisecting GlcNAc.

Authors:  Yasuhiko Kizuka; Naoyuki Taniguchi
Journal:  Glycoconj J       Date:  2018-06-16       Impact factor: 2.916

4.  An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III.

Authors:  Yuya Sato; Tomoya Isaji; Michiko Tajiri; Shumi Yoshida-Yamamoto; Tsuyoshi Yoshinaka; Toshiaki Somehara; Tomohiko Fukuda; Yoshinao Wada; Jianguo Gu
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

5.  Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels.

Authors:  Jishun Lu; Tomoya Isaji; Sanghun Im; Tomohiko Fukuda; Akihiko Kameyama; Jianguo Gu
Journal:  J Biol Chem       Date:  2016-01-22       Impact factor: 5.157

Review 6.  Genetic basis for the lack of N-glycolylneuraminic acid expression in human tissues and its implication to human evolution.

Authors:  Akemi Suzuki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2006-05       Impact factor: 3.493

7.  The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans.

Authors:  Paweł Link-Lenczowski; Monika Bubka; Crina I A Balog; Carolien A M Koeleman; Terry D Butters; Manfred Wuhrer; Anna Lityńska
Journal:  Glycoconj J       Date:  2018-03-03       Impact factor: 2.916

8.  DNA hypomethylation upregulates expression of the MGAT3 gene in HepG2 cells and leads to changes in N-glycosylation of secreted glycoproteins.

Authors:  Marija Klasić; Jasminka Krištić; Petra Korać; Tomislav Horvat; Dora Markulin; Aleksandar Vojta; Karli R Reiding; Manfred Wuhrer; Gordan Lauc; Vlatka Zoldoš
Journal:  Sci Rep       Date:  2016-04-13       Impact factor: 4.379

9.  Atomic visualization of a flipped-back conformation of bisected glycans bound to specific lectins.

Authors:  Masamichi Nagae; Mayumi Kanagawa; Kana Morita-Matsumoto; Shinya Hanashima; Yasuhiko Kizuka; Naoyuki Taniguchi; Yoshiki Yamaguchi
Journal:  Sci Rep       Date:  2016-03-14       Impact factor: 4.379

Review 10.  Improving Immunotherapy Through Glycodesign.

Authors:  Matthew J Buettner; Sagar R Shah; Christopher T Saeui; Ryan Ariss; Kevin J Yarema
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.